Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

by Vacirca, Jeffrey L., Acs, Peter. I., Tabbara, Imad A., Rosen, Peter. J., Lee, Peter, Lynam, Eric
Published 2013

A Portable Platform for Evaluation of Visual Performance in Glaucoma Patients

by Rosen, Peter N., Boer, Erwin R., Gracitelli, Carolina P. B., Abe, Ricardo Y., Diniz-Filho, Alberto, Marvasti, Amir H., Medeiros, Felipe A.
Published 2015

Predicting Risk of Motor Vehicle Collisions in Patients with Glaucoma: A Longitudinal Study

by Gracitelli, Carolina P. B., Tatham, Andrew J., Boer, Erwin R., Abe, Ricardo Y., Diniz-Filho, Alberto, Rosen, Peter N., Medeiros, Felipe A.
Published 2015

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors

by Papadopoulos, Kyriakos P., Burris, Howard A., Gordon, Michael, Lee, Peter, Sausville, Edward A., Rosen, Peter J., Patnaik, Amita, Cutler, Richard E., Wang, Zhengping, Lee, Susan, Jones, Suzanne F., Infante, Jeffery R.
Published 2013

A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors

by Hong, David S., Rosen, Peter, Lockhart, A. Craig, Fu, Siqing, Janku, Filip, Kurzrock, Razelle, Khan, Rabia, Amore, Benny, Caudillo, Isaac, Deng, Hongjie, Hwang, Yuying C., Loberg, Robert, Ngarmchamnanrith, Gataree, Beaupre, Darrin M., Lee, Peter
Published 2015

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea

by Verstovsek, Srdan, Passamonti, Francesco, Rambaldi, Alessandro, Barosi, Giovanni, Rosen, Peter J, Rumi, Elisa, Gattoni, Elisabetta, Pieri, Lisa, Guglielmelli, Paola, Elena, Chiara, He, Shui, Contel, Nancy, Mookerjee, Bijoyesh, Sandor, Victor, Cazzola, Mario, Kantarjian, Hagop M, Barbui, Tiziano, Vannucchi, Alessandro M
Published 2014